An Investigator-sponsored study on rFVIIa prophylaxis in children with haemophilia A and inhibitors Estudio promovido por el investigador sobre profilaxis con rFVIIa en niños con hemofilia A e inhibidores

Registry ID

EUCTR2009-010172-21

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Elena Santagostino

Start date

2009-08-27

Last update

2026-08-16

Conditions

• Hemophilia A
• Hemofilia A
• Haemophilia A

Summary

The objective of this study is to evaluate the efficacy and safety of a prophylactic regimen with rFVIIa in reducing the frequency of joint bleeds and the development of signs of joint damage including synovitis, as measured by the Hemophilia Joint Health Score (HJHS), in children with haemophilia A who develop high-responding inhibitors.

Locations

• , , Spain
• , , Germany
• , , Poland
• , , Italy
• , , France

Related clinical trials

• Prevention of bleeding in haemophilia A by prophylactic treatment with Nuwiq®
• A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
• A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
• A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
• A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
• A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

View on source registry